| 000 | 01640cam a2200277 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030814.0 | ||
| 008 | 130328s2011 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aGift | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.34.M.Sc.2011.No.S | ||
| 100 | 0 | _aNoha Hazem Mahmoud Ali Atta | |
| 245 | 1 | 0 |
_aSynthesis and biological evaluation of novel celecoxib analogues and their evaluation as cyclooxygenases and phosphodiesterase 5 inhibitors / _cNoha Hazem Mahmoud Ali Atta ; Supervised Ashraf H. Abadi |
| 246 | 1 | 5 | _aالتشييد والتقييم البيولوجى من مشبهات السليكوكسيب وتقيمها كمثبطات انزيمات السيكلواوكسيجيناز والفوسفودايستراز5 |
| 260 |
_aCairo : _bNoha Hazem Mahmoud Ali Atta , _c2011 |
||
| 300 |
_a82Leaves : _bcharts , facsimiles ; _c30cm |
||
| 502 | _aThesis (M.Sc.) - German University - Faculty of Postgraduate studies and scientific Research - Department of Pharmaceutical Chemistry | ||
| 520 | _aNon-selective cyclooxgenase (COX) inhibitors are effective anti-inflammatory agents . However , side effects such as gastric ulcers and abdominal pain have been reported . Selective cyclooxygenase-2 (COX-2) inhibitors have less gastric side effects but they were reported to increase the susceptibility of systemic hypertension and thromboembolic complication such as myocardial infarction | ||
| 700 | 0 |
_aAshraf H. Abadi , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c42298 _d42298 |
||